Cardiovascular function and prognosis of patients with heart failure coexistent with chronic obstructive pulmonary disease

Journal of Cardiology

Volumn 64, Issue 4, 2014, Pages 256-264

  Yoshihisa, Akiomi ^a   Takiguchi, Mai ^a   Shimizu, Takeshi ^a   Nakamura, Yuichi ^a   Yamauchi, Hiroyuki ^a   Iwaya, Shoji ^a   Owada, Takashi ^a   Miyata, Makiko ^a   Abe, Satoshi ^a   Sato, Takamasa ^a   Suzuki, Satoshi ^a   Oikawa, Masayoshi ^a   Kobayashi, Atsushi ^a   Yamaki, Takayoshi ^a   Sugimoto, Koichi ^a   Kunii, Hiroyuki ^a   Nakazato, Kazuhiko ^a   Suzuki, Hitoshi ^a   Saitoh, Shu ichi ^a   Takeishi, Yasuchika ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Chronic obstructive pulmonary disease; Prognosis; Right heart function; Troponin T; Vascular function

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; TROPONIN T;

ADULT; AGED; ANEMIA; ARTERIAL STIFFNESS; ARTICLE; CARDIO ANKLE VASCULAR INDEX; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR PARAMETERS; CHRONIC KIDNEY DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; DIGESTIVE SYSTEM HEMORRHAGE; DISEASE SEVERITY; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HEART ATRIUM FIBRILLATION; HEART DEATH; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE INJURY; HEART RIGHT VENTRICLE FUNCTION; HEART VENTRICLE FIBRILLATION; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; PEAK EXPIRATORY FLOW; PNEUMONIA; PREVALENCE; PROGNOSIS; PROSPECTIVE STUDY; SEPSIS; SPIROMETRY; COMPLICATION; MIDDLE AGED; SEVERITY OF ILLNESS INDEX;

ADRENERGIC BETA-ANTAGONISTS; AGED; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEVERITY OF ILLNESS INDEX; TROPONIN T; VASCULAR STIFFNESS;

EID: 84926257616     PISSN: 09145087     EISSN: 18764738     Source Type: Journal    
DOI: 10.1016/j.jjcc.2014.02.003     Document Type: Article

References (42)

1. Boschetto P., Beghe B., Fabbri L.M., Ceconi C. Link between chronic obstructive pulmonary disease and coronary artery disease: implication for clinical practice. Respirology 2012, 17:422-431.
2. Hawkins N.M., Petrie M.C., Jhund P.S., Chalmers G.W., Dunn F.G., McMurray J.J. Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology. Eur J Heart Fail 2009, 11:130-139.
3. Le Jemtel T.H., Padeletti M., Jelic S. Diagnostic and therapeutic challenges in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure. J Am Coll Cardiol 2007, 49:171-180.
4. McMurray J.J., Adamopoulos S., Anker S.D., Auricchio A., Bohm M., Dickstein K., Falk V., Filippatos G., Fonseca C., Gomez-Sanchez M.A., Jaarsma T., Kober L., Lip G.Y., Maggioni A.P., Parkhomenko A., et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2012, 14:803-869.
5. Kwon B.J., Kim D.B., Jang S.W., Yoo K.D., Moon K.W., Shim B.J., Ahn S.H., Cho E.J., Rho T.H., Kim J.H. Prognosis of heart failure patients with reduced and preserved ejection fraction and coexistent chronic obstructive pulmonary disease. Eur J Heart Fail 2010, 12:1339-1344.
6. Staszewsky L., Wong M., Masson S., Barlera S., Carretta E., Maggioni A.P., Anand I.S., Cohn J.N., Tognoni G., Latini R. Clinical, neurohormonal, and inflammatory markers and overall prognostic role of chronic obstructive pulmonary disease in patients with heart failure: data from the Val-HeFT heart failure trial. J Card Fail 2007, 13:797-804. Valsartan Heart Failure Trial Investigators.
7. Rusinaru D., Saaidi I., Godard S., Mahjoub H., Battle C., Tribouilloy C. Impact of chronic obstructive pulmonary disease on long-term outcome of patients hospitalized for heart failure. Am J Cardiol 2008, 101:353-358.
8. Iversen K.K., Kjaergaard J., Akkan D., Kober L., Torp-Pedersen C., Hassager C., Vestbo J., Kjoller E. The prognostic importance of lung function in patients admitted with heart failure. Eur J Heart Fail 2010, 12:685-691. ECHOS Lung Function Study Group.
9. Raymond I., Pedersen F., Steensgaard-Hansen F., Green A., Busch-Sorensen M., Tuxen C., Appel J., Jacobsen J., Atar D., Hildebrandt P. Prevalence of impaired left ventricular systolic function and heart failure in a middle aged and elderly urban population segment of Copenhagen. Heart 2003, 89:1422-1429.
10. Siirila-Waris K., Lassus J., Melin J., Peuhkurinen K., Nieminen M.S., Harjola V.P. Characteristics, outcomes, and predictors of 1-year mortality in patients hospitalized for acute heart failure. Eur Heart J 2006, 27:3011-3017. FINN-AKVA Study Group.
11. Damy T., Kallvikbacka-Bennett A., Goode K., Khaleva O., Lewinter C., Hobkirk J., Nikitin N.P., Dubois-Rande J.L., Hittinger L., Clark A.L., Cleland J.G. Prevalence of, associations with, and prognostic value of tricuspid annular plane systolic excursion (TAPSE) among out-patients referred for the evaluation of heart failure. J Card Fail 2012, 18:216-225.
12. Ghio S., Temporelli P.L., Klersy C., Simioniuc A., Girardi B., Scelsi L., Rossi A., Cicoira M., Tarro Genta F., Dini F.L. Prognostic relevance of a non-invasive evaluation of right ventricular function and pulmonary artery pressure in patients with chronic heart failure. Eur J Heart Fail 2013, 15:408-414.
13. Szwejkowski B.R., Elder D.H., Shearer F., Jack D., Choy A.M., Pringle S.D., Struthers A.D., George J., Lang C.C. Pulmonary hypertension predicts all-cause mortality in patients with heart failure: a retrospective cohort study. Eur J Heart Fail 2012, 14:162-167.
14. Ather S., Hira R.S., Shenoy M., Fatemi O., Deswal A., Aguilar D., Ramasubbu K., Bolos M., Chan W., Bozkurt B. Recurrent low-level troponin I elevation is a worse prognostic indicator than occasional injury pattern in patients hospitalized with heart failure. Int J Cardiol 2013, 166:394-398.
15. Savard P., Rouleau J.L., Ferguson J., Poitras N., Morel P., Davies R.F., Stewart D.J., Talajic M., Gardner M., Dupuis R., Lauzon C., Sussex B., Potvin L., Warnica W. Risk stratification after myocardial infarction using signal-averaged electrocardiographic criteria adjusted for sex, age, and myocardial infarction location. Circulation 1997, 96:202-213.
16. Katz S.D., Hryniewicz K., Hriljac I., Balidemaj K., Dimayuga C., Hudaihed A., Yasskiy A. Vascular endothelial dysfunction and mortality risk in patients with chronic heart failure. Circulation 2005, 111:310-314.
17. Meguro T., Nagatomo Y., Nagae A., Seki C., Kondou N., Shibata M., Oda Y. Elevated arterial stiffness evaluated by brachial-ankle pulse wave velocity is deleterious for the prognosis of patients with heart failure. Circ J 2009, 73:673-680.
18. McKee P.A., Castelli W.P., McNamara P.M., Kannel W.B. The natural history of congestive heart failure: the Framingham study. N Engl J Med 1971, 285:1441-1446.
19. National Institute of Health, Lung, and Blood Institute Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO workshop report 2013, http://goldcopd.org/Guidelines/guidelines-resources.html.
20. Celli B.R., MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004, 23:932-946. ATS/ERS Task Force.
21. Levey A.S., Coresh J., Greene T., Stevens L.A., Zhang Y.L., Hendriksen S., Kusek J.W., Van Lente F. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006, 145:247-254. Chronic Kidney Disease Epidemiology Collaboration.
22. Charakida M., Masi S., Luscher T.F., Kastelein J.J., Deanfield J.E. Assessment of atherosclerosis: the role of flow-mediated dilatation. Eur Heart J 2010, 31:2854-2861.
23. Shirai K., Hiruta N., Song M., Kurosu T., Suzuki J., Tomaru T., Miyashita Y., Saiki A., Takahashi M., Suzuki K., Takata M. Cardio-ankle vascular index (CAVI) as a novel indicator of arterial stiffness: theory, evidence and perspectives. J Atheroscler Thromb 2011, 18:924-938.
24. Rudski L.G., Lai W.W., Afilalo J., Hua L., Handschumacher M.D., Chandrasekaran K., Solomon S.D., Louie E.K., Schiller N.B. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr 2010, 23:685-713.
25. Mills N.L., Miller J.J., Anand A., Robinson S.D., Frazer G.A., Anderson D., Breen L., Wilkinson I.B., McEniery C.M., Donaldson K., Newby D.E., Macnee W. Increased arterial stiffness in patients with chronic obstructive pulmonary disease: a mechanism for increased cardiovascular risk. Thorax 2008, 63:306-311.
26. Curkendall S.M., DeLuise C., Jones J.K., Lanes S., Stang M.R., Goehring E., She D. Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients. Ann Epidemiol 2006, 16:63-70.
27. Kuralay E., Cingoz F., Kilic S., Bolcal C., Gunay C., Demirkilic U., Tatar H. Supraventricular tachyarrythmia prophylaxis after coronary artery surgery in chronic obstructive pulmonary disease patients (early amiodarone prophylaxis trial). Eur J Cardiothorac Surg 2004, 25:224-230.
28. Agarwal S.K., Heiss G., Barr R.G., Chang P.P., Loehr L.R., Chambless L.E., Shahar E., Kitzman D.W., Rosamond W.D. Airflow obstruction, lung function, and risk of incident heart failure: the Atherosclerosis Risk in Communities (ARIC) study. Eur J Heart Fail 2012, 14:414-422.
29. Sabit R., Bolton C.E., Fraser A.G., Edwards J.M., Edwards P.H., Ionescu A.A., Cockcroft J.R., Shale D.J. Sub-clinical left and right ventricular dysfunction in patients with COPD. Respir Med 2010, 104:1171-1178.
30. Jezek V., Schrijen F., Sadoul P. Right ventricular function and pulmonary hemodynamics during exercise in patients with chronic obstructive bronchopulmonary disease. Cardiology 1973, 58:20-31.
31. Vizza C.D., Lynch J.P., Ochoa L.L., Richardson G., Trulock E.P. Right and left ventricular dysfunction in patients with severe pulmonary disease. Chest 1998, 113:576-583.
32. Minai O.A., Chaouat A., Adnot S. Pulmonary hypertension in COPD: epidemiology, significance, and management: pulmonary vascular disease: the global perspective. Chest 2010, 137:39S-51S.
33. Barr R.G., Bluemke D.A., Ahmed F.S., Carr J.J., Enright P.L., Hoffman E.A., Jiang R., Kawut S.M., Kronmal R.A., Lima J.A., Shahar E., Smith L.J., Watson K.E. Percent emphysema, airflow obstruction, and impaired left ventricular filling. N Engl J Med 2010, 362:217-227.
34. Funk G.C., Lang I., Schenk P., Valipour A., Hartl S., Burghuber O.C. Left ventricular diastolic dysfunction in patients with COPD in the presence and absence of elevated pulmonary arterial pressure. Chest 2008, 133:1354-1359.
35. Neukamm A.M., Hoiseth A.D., Hagve T.A., Soyseth V., Omland T. High-sensitivity cardiac troponin T levels are increased in stable COPD. Heart 2013, 99:382-387.
36. Soyseth V., Bhatnagar R., Holmedahl N.H., Neukamm A., Hoiseth A.D., Hagve T.A., Einvik G., Omland T. Acute exacerbation of COPD is associated with fourfold elevation of cardiac troponin T. Heart 2013, 99:122-126.
37. Mentz R.J., Fiuzat M., Wojdyla D.M., Chiswell K., Gheorghiade M., Fonarow G.C., O'Connor C.M. Clinical characteristics and outcomes of hospitalized heart failure patients with systolic dysfunction and chronic obstructive pulmonary disease: findings from OPTIMIZE-HF. Eur J Heart Fail 2012, 14:395-403.
38. De Blois J., Simard S., Atar D., Agewall S. COPD predicts mortality in HF: the Norwegian Heart Failure Registry. J Card Fail 2010, 16:225-229. Norwegian Heart Failure Registry.
39. Peacock W.F., De Marco T., Fonarow G.C., Diercks D., Wynne J., Apple F.S., Wu A.H. Cardiac troponin and outcome in acute heart failure. N Engl J Med 2008, 358:2117-2126. ADHERE Investigators.
40. Sinden N.J., Stockley R.A. Systemic inflammation and comorbidity in COPD: a result of 'overspill' of inflammatory mediators from the lungs? Review of the evidence. Thorax 2010, 65:930-936.
41. Saunders J.T., Nambi V., de Lemos J.A., Chambless L.E., Virani S.S., Boerwinkle E., Hoogeveen R.C., Liu X., Astor B.C., Mosley T.H., Folsom A.R., Heiss G., Coresh J., Ballantyne C.M. Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the Atherosclerosis Risk in Communities Study. Circulation 2011, 123:1367-1376.
42. Hurdman J., Condliffe R., Elliot C.A., Swift A., Rajaram S., Davies C., Hill C., Hamilton N., Armstrong I.J., Billings C., Pollard L., Wild J.M., Lawrie A., Lawson R., Sabroe I., et al. Pulmonary hypertension in COPD: results from the ASPIRE registry. Eur Respir J 2013, 41:1292-1301.